Amazon has moved into India’s diagnostics sector with a service designed to maximise speed and reach. So what does this mean for testing firms around the world? Are they about to get swallowed up by the US tech giant? 

Amazon Diagnostics offers home sample collection in under an hour and digital results in as little as six, covering more than 450 pin codes and 800-plus tests in six cities.

The launch, under the Amazon Medical division, is in partnership with Orange Health Labs and is live in Bengaluru, Delhi, Gurgaon, Noida, Mumbai, and Hyderabad. Customers can arrange tests, track progress, and get results entirely within the Amazon app — an attempt to compress a process that is usually slow and fragmented into something near-instant.

Is this the start of a global health takeover?

It sounds like it, but…

Almost everything you’d assume about this story is wrong. Here’s what you need to know:

• This isn’t new (in India) 
• At-home blood draws are established in India
• Firms like Dr Lal PathLabs have been doing it for years
• Labour is cheap and the basic infrastructure is in place
• The Indian health system is set up for pay as you go 

So what is Amazon really testing? 

They know they can nail logistics. Now they want to be your first call for health. Is the long game a global rollout? Maybe. But it’s not as simple as replicating the Indian experiment. 

Try it in the US and you’ll hit a wall

• Most tests need to be requested by a doctor
• Like-for-like service would be cost-prohibitive
• Insurance system = friction and delay 

In the UK, they’ve got problems

• No cheap labour to draw blood at home
• NHS has conditioned people not to pay direct

Amazon can’t bulldoze the US healthcare system or the NHS. But they can put themselves in front of both by offering:

• Mail-order test kits
• Direct-to-consumer pricing
• Results in-app
• Over time: advice layered on top
• Eventually: treatment options too

Who should be on high alert? 

Blood testing brands. Compete on price and speed and you’ll lose. If you were Thriva, Randox Health or Medichecks, would you be nervous? 

It looks like Amazon want to move aggressively into this space but health is more emotional than delivering parcels. There are two big questions they still need to answer:

Can they build enough trust? 

Can they make a difference? People don’t want more data. They want to know what to do with it. They want change.

The move also raised questions around Amazon’s motives. “Let’s assume that Amazon can pull this off. What is it at the core?,” asked Dr Dan Reardon, metabolic health doctor and founder of GoMetabolic “It’s about data extraction at a molecular level. By offering fast, at-home blood tests, Amazon can map your biochemistry, hormonal rhythms, inflammation markers, and potentially your genetic predispositions. This makes your health profile a product. Healthcare surveillance sugar coated as convenience? The collection of high-fidelity biometric data that can feed its algorithms, influence insurance premiums, shape pharmaceutical partnerships, and even guide targeted marketing based on your metabolic vulnerabilities.”

As you might expect, Amazon put out some by-the-numbers soundbites. “Amazon Diagnostics represents a significant step forward in making healthcare more accessible, reliable and convenient for all our customers,” said Jayaramakrishnan Balasubramanian, Category Leader at Amazon Medical. 

For others, the news was less of an innovation than the press release would have you believe. “This service already exists in the UK” says Shaun Hemmings, a strategic operations leader specialising in healthcare. “Many Private Healthcare Providers (particularly in London) offer this, including the six-hour turnaround time.

“Direct to consumer brands such as Medichecks also offer this, with the option to pay circa £35 extra for a nurse or phlebotomist to come and collect your sample. I don’t think the NHS is the stumbling block for the UK market, but the trade off between convenience, cost and result turn around time is

“Many direct to consumer providers offer capillary blood draws as standard because they are convenient and can be taken by patients. Yet the vast majority of private providers will take venous samples in clinic (for a premium). The sweet spot is found somewhere in between balancing cost and convenience with direct routes into laboratories to ensure a quick turn around time.”